🔎 Trials Near Me

Akèy › Maladi kadyovaskilè › Kalifòni › Torrance

Etid klinik pou Maladi kadyovaskilè nan Torrance, CA

7 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan ak bò kote Torrance (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Ap rekriteFaz 4
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06909565

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Ap rekriteFaz 3
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
Laj 45 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07613294

Product Surveillance Registry

Ap rekriteEtid obsèvasyon
  • Torrance, Torrance
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Ap rekriteFaz 3
  • Clinical Trial Site, Torrance
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Ap rekriteFaz 2
  • Clinical Research Site, Torrance
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3
  • Research Site, Torrance
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Etid Maladi kadyovaskilè nan lòt vil

Lòt etid nan Torrance

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.